J Korean Rheum Assoc.  1996 Jul;3(2):187-194.

Effect of Cyclophospharmide Pulse and Combined with Per Oral Low Dose Glucorticoid on Pulmonary Fibrosis in Patient with Sistemic Sclerosis

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea.

Abstract


OBJECTIVE
To investigate the efficacy of combined intravenous cyclophophamide pulse and low dose oral prednisolone treatment in patients with systemic sclerosis with -interstitial lung disease. METHOD: Six patients with systemic sclerosis with interstitial lung disease were treated with intravenous infusion of cyclophosphamide(0. 75g/m2 body surface area) and low dose oral prednisolone (10mg/day).
RESULTS
1) Respiratory symptoms, cough and dyspnea, were improved in all patients in both frequency and severity. 2) The mean value of FVC, FEV1, and DLC test showed tendency of increase during the follow up period (upto 24 months) compared to decrease in the past studies. 3)There was no serious side effect during the trreatment. Herpes zoster was developede in I patient during treament.
CONCLUSIONS
Combined intravenous cyclophosphamide pulse and low dose oral prednisolone treatment is effective for the patients with systemic sclerosis with interstitial lung disease. A controlled prospective trial is warranted in patients with systemic sclerosis with interstitial lung disease.

Keyword

Scleroderma; Pulmonary fibrosis; Cyclophosphamide; Treatment

MeSH Terms

Cough
Cyclophosphamide
Dyspnea
Follow-Up Studies
Herpes Zoster
Humans
Infusions, Intravenous
Lung Diseases
Lung Diseases, Interstitial
Prednisolone
Pulmonary Fibrosis*
Scleroderma, Systemic
Sclerosis*
Cyclophosphamide
Prednisolone
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr